A case of refractory IgG4-related disease successfully treated with daratumumab and lenalidomide.

Coulomb, Denis; Szablewski, Vanessa; Robert, Nicolas; Dupuy, Anne-Marie; Berrahouane, Rayane; Goulabchand, Radjiv; Moreaux, Jérôme; Maria, Alexandre Thibault Jacques; Herbaux, Charles.

Afiliação

Coulomb D; Department of Clinical Hematology, CHU de Montpellier, Montpellier, France.
Szablewski V; Department of Pathology, CHU de Montpellier, Montpellier, France.
Robert N; Department of Biological Hematology, CHU de Montpellier, Montpellier, France.
Dupuy AM; Department of Biochemistry, CHU de Montpellier, Montpellier, France.
Berrahouane R; Department of Clinical Hematology, CHU de Montpellier, Montpellier, France.
Goulabchand R; Desbrest Institute of Epidemiology and Public Health, University of Montpellier and INSERM, Montpellier, France.
Moreaux J; Department of Biological Hematology, CHU de Montpellier, Montpellier, France.
Maria ATJ; UMR CNRS-UM 9002, Institute of Human Genetics, Montpellier, France.
Herbaux C; Institut Universitaire de France (IUF), Paris, France.

Rheumatology (Oxford) ; 2024 Aug 24.

Article em En | MEDLINE | ID: mdl-39180414

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article